Interaction of peptides with biomembranes assessed by potential-sensitive fluorescent probes

Journal of Peptide Science

Volumn 14, Issue 4, 2008, Pages 407-415

  Matos, Pedro M ^a   Gonçalves, Sónia ^a   Santos, Nuno C ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Bioactive peptides; Biomembranes; Dipole potential; Fluorescent probes; Surface potential; Transmembrane potential

Indexed keywords

4 [2 [6 (DIOCTYLAMINO) 2 NAPHTHALENYL]ETHENYL] 1 (3 SULFOPROPYL)PYRIDINIUM; BACITRACIN; FLUORESCENT DYE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; PEPTIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PROTEIN P25; UNCLASSIFIED DRUG;

BACTERIAL MEMBRANE; BINDING SITE; BIOCOMPATIBILITY; CELL LABELING; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CELL SURFACE; DRUG BINDING; DRUG INTERACTION; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IONIC STRENGTH; LIPID MEMBRANE; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIMIAN IMMUNODEFICIENCY VIRUS;

CELL MEMBRANE; FLUORESCEINS; FLUORESCENT DYES; KINETICS; MEMBRANE POTENTIALS; MODELS, CHEMICAL; PEPTIDES; PHOSPHATIDYLETHANOLAMINES; PYRIDINIUM COMPOUNDS; SENSITIVITY AND SPECIFICITY;

EID: 42149117742     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1005     Document Type: Review

References (57)

1. Burton PS, Conradi RA, Ho NF, Hilgers AR, Borchardt RT. How structural features influence the biomembrane permeability of peptides. J. Pharm. Sci. 1996; 85: 1336-1340.
2. Fahr A, van Hoogevest P, May S, Bergstrand N, Leigh MLS. 'Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Eur. J. Pharm. Sci. 2005; 26: 251-265.
3. Castanho MA, Fernandes MX. Lipid membrane-induced optimization for ligand-receptor docking: recent tools and insights for the "membrane catalysis" model. Eur. Biophys. J. 2006: 35: 92-103.
4. Killian JA, Nyholm, TK. Peptides in lipid bilayers: the power of simple models. Curr. Opin. Struct. Biol. 2006; 16: 473-479.
5. Santos NC, Prieto M, Castanho MA. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods. Biochim. Biophys. Acta 2003; 1612: 123-135.
6. McLaughlin S. The electrostatic properties of membranes. Annu. Rev. Biophys. Biophys. Chem. 1989; 18: 113-136.
7. Langner M, Kubica K. The electrostatics of lipid surfaces. Chem. Phys. Lipids 1999; 101: 3-35.
8. Cevc G. Membrane electrostatics. Biochim. Biophys. Acta 1990; 1031: 311-382.
9. Wall J, Golding CA, Van Veen M, O'Shea P. The use of fluorescein phosphatidylethanolamine (FPE) as a real-time probe for peptide-membrane interactions. Mol. Membr. Biol. 1995; 12: 183-192.
10. Thelen M, Petrone G, O'Shea PS, Azzi A. The use of fluorescein-dipalmitoylphosphatidylethanolamine for measuring pH-changes in the internal compartment of phospholipid vesicles. Biochim. Biophys. Acta 1984; 766: 161-168.
11. Soucaille P, Prats M, Tocanne JF, Teissie J. Use of a fluorescein derivative of phosphatidylethanolamine as a pH probe at water/lipid interfaces. Biochim. Biophys. Acta 1988: 939: 289-294.
12. 1-ATPase using N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl- sn-glycero-3-phosphoethano lamine, triethylammonium salt. Anal. Biochem. 2005; 344: 102-107.
13. ThelenM, O'Shea PS, Petrone G, Azzi A. Proton translocation by a native and subunit III-depleted cytochrome c oxidase reconstituted into phospholipid vesicles. Use of fluorescein-phosphatidylethanolamine as an intravesicular pH indicator. J. Biol. Chem. 1985; 260: 3626-3631.
14. O'Shea P. Intermolecular interactions with/within cell membranes and the trinity of membrane potentials: kinetics and imaging. Biochem. Soc. Trans. 2003: 31: 990-996.
15. Wall J, Ayoub F, O'Shea P. Interactions of macromolecules with the mammalian cell surface. J. Cell Sci. 1995; 108: 2673-2682.
16. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J. Membr. Biol. 1997; 156: 197-211.
17. Chupin V, Leenhouts JM, de Kroon AI, de Kruijff B. Cardiolipin modulates the secondary structure of the presequence peptide of cytochrome oxidase, subunit IV: a 2D 1H-NMR study. FEBS Lett. 1995; 373: 239-244.
18. Matsuzaki K, Yoneyama S, Miyajima K. Pore formation and translocation of melittin. Biophys. J. 1997: 73: 831-838.
19. Golding C, Senior S, Wilson MT, O'Shea P. Time resolution of binding and membrane insertion of a mitochondrial signal peptide: correlation with structural changes and evidence for cooperativity. Biochemistry 1996; 35: 10931-10937.
20. Chan DC, Kim PS. HIV entry and its inhibition. Cell 1998; 93: 681-684.
21. Cladera J, Martin I, O'Shea P. The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface. EMBO J. 2001; 20: 19-26.
22. Sim B, Cladera J, O'Shea P. 171bronectin interactions with osteoblasts: identification of a non-integrin-mediated binding mechanism using a real-time fluorescence binding assay. J. Biomed. Mater. Res. A 2004; 68: 352-359.
23. Fitchen N, O'Shea P, Williams P, Hardie KR. Electrostatic sensor for identifying interactions between peptides and bacterial membranes. Mol. Immunol. 2003; 40: 407-411.
24. Gawrisch K, Ruston D, Zimmerberg J, Parsegian VA, Rand RP, Fuller N. Membrane dipole potentials, hydration forces, and the ordering of water at membrane surfaces. Biophys. J. 1992; 61: 1213-1223.
25. Zheng C, Vanderkooi G. Molecular origin of the internal dipole potential in lipid bilayers: calculation of the electrostatic potential. Biophys. J. 1992; 63: 935-941.
26. Clarke P.J. The dipole potential of phospholipid membranes and methods for its detection. Adv. Colloid Interface Sci. 2001; 89-90: 263-281.
27. Gross E, Bedlack RS, Loew LM. Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys. J. 1994; 67: 208-216.
28. Zouni A, Clarke RJ, Holzwarth JF. Kinetics of the solubilization of styryl dye aggregates by lipid vesicles. J. Phys. Chem. 1994: 98: 1732-1738.
29. Fluhler E, Burnham VG, Loew LM. Spectra, membrane binding, and potentiometric responses of new charge shift probes. Biochemistry 1985; 24: 5749-5755.
30. Loew LM, Bonneville GW, Surow J. Charge shift optical probes of membrane potential. theory. Biochemistry 1978; 17: 4065-4071.
31. Bublitz GU, Boxer SG. Stark spectroscopy: applications in chemistry, biology, and materials science. Annu. Rev. Phys. Chem. 1997; 48: 213-242.
32. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985; 260: 3440-3450.
33. Vitha MF, Clarke RJ. Comparison of excitation and emission ratiometric fluorescence methods for quantifying the membrane dipole potential. Biochim. Biophys. Acta 2007; 1768: 107-114.
34. Clarke RJ, Kane DJ. Optical detection of membrane dipole potential: avoidance of fluidity and dye-induced effects. Biochim. Biophys. Acta 1997; 1323: 223-239.
35. Clarke RJ. Effect of lipid structure on the dipole potential of phosphatidylcholine bilayers. Biochim. Biophys. Acta 1997; 1327: 269-278.
36. Cladera J, O'Shea P. Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide. Biophys. J. 1998; 74: 2434-2442.
37. Franklin JC, Cafiso DS. Internal electrostatic potentials in bilayers: measuring and controlling dipole potentials in lipid vesicles. Biophys. J. 1993; 65: 289-299.
38. Cladera J, Martin I, Ruysschaert JM, O'Shea P. Characterization of the sequence of interactions of the fusion domain of the simian immunodeficiency virus with membranes. Role of the membrane dipole potential. J. Biol. Chem. 1999; 274: 29951-29959.
39. Buzon V, Cladera J. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential. Biochemistry 2006; 45: 15768-15775.
40. Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM. Lipid composition and fluidity of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 900-904.
41. Aloia RC, Tian H, Jensen FC. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 5181-5185.
42. Asawakarn T, Cladera J, O'Shea P. Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells. J. Biol. Chem. 2001; 276: 38457-38463.
43. Shah P, Jogani V, Bagchi T, Misra A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol. Prog. 2006; 22: 186-198.
44. Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 1998; 37: 3594-3601.
45. Cladera J, O'Shea P, Hadgraft J, Valenta C. Influence of molecular dipoles on human skin permeability: Use of 6-ketocholestanol to enhance the transdermal delivery of bacitracin. J. Pharm. Sci. 2003; 92: 1018-1027.
46. Klymchenko AS, Duportail G, Mely Y, Demchenko AP. Ultrasensitive two-color fluorescence probes for dipole potential in phospholipid membranes. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 11219-11224.
47. Shynkar VV, Klymchenko AS, Duportail G, Demchenko AP, Mely Y. Two-color fluorescent probes for imaging the dipole potential of cell plasma membranes. Biochim. Biophys. Acta 2005; 1712: 128-136.
48. Deshayes S, Plenat T, Charnet P, Divita G, Molle G, Heitz F. Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration. Biochim. Biophys. Acta 2006; 1758: 1846-1851.
49. Terrone D, Sang SL, Roudaia L, Silvius JR. Penetrating and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry 2003; 42: 13787-13799.
50. Haugland RP. Probes for membrane potential. The Handbook - A Guide to Fluorescent Probes and Labelling Technologies. Invitrogen Molecular Probes: Eugene, OR, 2005; 973-986.
51. Moll GN, Brul S, Konings WN, Driessen AJ. Comparison of the membrane interaction and permeabilization by the designed peptide Ac-MB21-NH2 and truncated dermaseptin S3. Biochemistry 2000; 39: 11907-11912.
52. Rintoul MR, de Arcuri BF, Morero RD. Effects of the antibiotic peptide microcin J25 on liposomes: role of acyl chain length and negatively charged phospholipid. Biochim. Biophys. Acta 2000; 11509: 65-72.
53. Ibrahim HR, Sugimoto Y, Aoki T. Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochim. Biophys. Acta 2000; 1523: 196-205.
54. Tiriveedhi V, Butko P. A fluorescence spectroscopy study on the interactions of the TAT-PTD peptide with model lipid membranes. Biochemistry 2007; 46: 3888-3895.
55. Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem. Biophys. Res. Commun. 2006; 349: 769-774.
56. Nuding S, Fellermann K, Wehkamp J, Mueller HA, Stange EF. A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J. Microbiol. Methods 2006; 65: 335-345.
57. Yang ST, Shin SY, Kim JI. Interaction mode of a symmetric Trp-rich undeca peptide PST11-RK with lipid bilayers. FEBS Lett. 2007; 581: 157-163.